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Abstract
Background: The aim of this study was to evaluate the antiplaque effect of a new alcohol free essential oil
mouthwash with respect to a control of an essential oil with alcohol mouthwash, using an in vivo plaque regrowth
model of 3-days.
Methods: The study was designed as a double-masked, randomized, crossover clinical trial, involving 30 volunteers
to compare two different essential oil containing mouthwashes, during a 3-day plaque accumulation model. After
receiving a thorough professional prophylaxis at the baseline, over the next 3-days each volunteer refrained from
all oral hygiene measures and had two daily rinses with 20 ml of the test mouthwash (alcohol free essential oil) or
the control mouthwash (essential oil with alcohol). At the end of the each experimental period, plaque was
assessed and the panelists filled out a questionnaire. Each subject underwent a 14 days washout period and there
was a second allocation.
Results: The essential oil mouthwash with ethanol shows a better inhibitory effect of plaque regrowth in 3-days
than the mouthwash test with only essential oil in the whole mouth (plaque index = 2.18 against 2.46,
respectively, p < 0.05); for the lower jaw (plaque index = 2.28 against 2.57, respectively, p < 0.05); for the upper jaw
(plaque index = 2.08 against 2.35, respectively, p < 0.05); for the incisors (plaque index = 1.93 against 2.27,
respectively, p < 0.05); and the canines (plaque index = 1.99 against 2.47, respectively, p < 0.05).
Conclusion: The essential oil containing mouthwash without alcohol seems to have a less inhibiting effect on the
plaque regrowth than the traditional alcoholic solution.
Trial Registration: ClinicalTrials.gov NCT01411618
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Background
The daily removal of supragingival dental plaque is a
major factor in the prevention of caries, gingivitis and
periodontitis. Proper control of bacterial plaque is
obtained through the mechanical removal of the biofilm
by the proper use of the toothbrush and floss. However,
some studies have shown that the mean time of brush-
ing tooth surfaces is less than that required to obtain a
proper cleaning [1] and only 2-10% of the patients use
dental floss regularly and effectively [2]. In addition, it
has been demonstrated that even after education and
motivation of the patient to the proper use of tooth-
brush and floss, its compliance is reduced with time [3].
T h er e s u l ti st h ep e r s i s t e n c eo fp l a q u ei ns o m ea r e a s ,
particularly on the interproximal surfaces of teeth. Many
studies have demonstrated the effectiveness and useful-
ness of antiseptic mouthwashes containing active ingre-
dients such as chlorhexidine (CHX) and essential oils
(EO) to prevent and control the formation of plaque
and gingivitis, when used in addition to mechanical pro-
cedures [4-7]. Chlorhexidine is still the gold standard
for its antimicrobial action and high substantiveness, but
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the formation of supragingival calculus limit its contin-
ued use [8]. Essential oil (EO) mouthwashes have been
used for years as an adjunct to brushing in addressing
oral hygiene. Their effectiveness in controlling plaque
and gingivitis are well documented in literature [9-14].
They kill microorganisms by destroying their cell walls
and inhibiting their enzymatic activity [15,16]. Further-
more, phenolic compounds like EOs are known to inter-
fere with the inflammation process [17,18]. The
antibacterial action is particularly effective for the ability
of the mouthwash with EOs to penetrate the biofilm
[19-21]. The traditional EO mouthwashes contain etha-
nol, a chemical used to dissolve numerous substances in
mouthwashes, including CHX. The concentration of
ethanol present in the mouthwash with EOs is more
than 20%, sufficient to dissolve the EOs but not enough
to carry out a direct antibacterial effect [22,23]. Many
aspects against the use of alcohol in mouthwashes, such
as its effects on the surfaces of composite restorations
[24] and its possible role in the formation of oropharyn-
geal cancer are being discussed [25,26]. Although a
direct correlation of the cause and effect between the
occurrence of oropharyngeal cancer and the use of
mouthwashes with alcohol [27], has not demonstrated
so far, it is considered desirable to eliminate ethanol for
use in daily mouthwash, bringing in search of new for-
mulations. Recently, an EOs containing mouthwash
without alcohol was introduced on the European market
(Daycare, Curaden, Kriens, and Suisse). To our knowl-
edge, to date there are no published data on the effec-
tiveness of this antimicrobial product. The rinsing with
this mouthwash can cause fewer side effects but, in con-
trast, it may be less effective.
The aim of this study was to evaluate the inhibitory
properties of a new alcohol free EO containing
mouthwash with respect to the traditional mouthwash
containing 21.3% ethanol, through a standard 3-days
plaque regrowth model.
Materials and methods
Study Population
Thirty healthy non-dental student volunteers (13
females and 17 males; age range 18 to 35 years; mean
age: 23.9 years) participated in the study. The subjects
were recruited through advertisements. All candidates
were screened for suitability by the research team.
Selection criteria were a dentition with ≥20 evaluable
teeth (minimum of five teeth per quadrant), no oral
lesions, no severe periodontal problems (no probing
depth ≥5 mm), and no removable prostheses or ortho-
dontic bands or appliances. Persons allergic to several
mouthwash components were excluded from the
study.
All eligible subjects were given oral and written infor-
mation about the products and the purpose of the study
and were asked to sign an informed consent. The study
was conducted from June 08, 2010 to September 21,
2010 in the Division of Periodontology, University of
L’Aquila, in accordance with the ethical principles origi-
nating in the Declaration of Helsinki and consistent
with good clinical practices. The study was not com-
menced until the approval of the ethics committee of
ASL 1 Avezzano - Sulmona - L’Aquila was obtained
(11/2010/SC).
Study Design
The study was designed as a double-masked, two-group
crossover randomized clinical trial (Figure 1). On day 1
of each of the 2 study periods, after disclosing the teeth,
the volunteers received an oral soft and hard tissue
examination and a professional scaling and polishing to
remove all calculus, plaque and extrinsic tooth stain.
This was performed using hand instruments, mechanical
scalers, rotating brushes with polishing paste, and dental
floss in the interproximal areas. To ensure that all
deposits were removed, a second disclosing episode was
carried out.
Volunteers were randomly assigned to the test or con-
trol group. Randomization was performed using compu-
ter-generated random numbers. A person not directly
involved in the research project carried out the alloca-
tion of test or control products.
The subjects in the test group received a bottle of
mouthrinse containing an alcohol free EO mouthwash
‡,
whereas subjects in the control group received a bottle
of mouthrinse containin a traditional alcohol containing
EO mouthwash
§. All bottles with mouthwash were pre-
weighed. All participants were instructed to refrain from
using any other means of oral hygiene during the
experimental period.
All subjects were instructed to rinse twice a day, in
the morning and in the evening, with 20 ml solution for
60 seconds. Subsequent rinsing with water was not
allowed. Written instructions were provided explaining
how to use the mouthwash. Rinsing was performed at
home without supervision. To check for compliance,
subjects were asked to note the times of day when they
rinsed.
After 3 days, all volunteers were disclosed with an ery-
throsine solution and the plaque in both groups was
recorded using the Quigley and Hein index as modified
by Turesky et al. [28]. All measurements were carried
out under the same conditions by the same blinded
investigator (DM). The examiner was trained and cali-
brated in the plaque scoring system. All returned
mouthwash bottles were weighed to calculate the
amount of mouth rinse used and to check for
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using a visual analog scale (VAS) designed to evaluate
their attitudes with regard to the product used. Subjects
marked a point on a 10-cm-long uncalibrated line with
t h en e g a t i v ee x t r e m er e s p o n s e( 0 )a tt h el e f te n da n d
the positive extreme response (10) at the right end [29].
A washout period of 14 days was instituted between
the treatments, when subjects resumed their normal
oral hygiene habits; following this 2-week washout per-
iod, all subjects underwent again a session of scaling in
order to get the plaque index to 0 and the procedures
were repeated with subjects using the alternative rinse.
Figure 1 Flow diagram illustrating the study design.
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The population size of the study was calculated a priori.
Using a power calculator, it was determined that ≥30
subjects were necessary so that a 20% reduction in para-
meter (hypothesis of plaque reduction tests compared to
control) with a 10% standard deviation as clinically rele-
vant, a power (1-b)o f≥ 80% was computed for the two-
sided null hypothesis, Ho. The plaque scores were used
as the main response variables. Mean plaque values
were calculated at the subject level and were considered
both in the totality of the oral cavity and for several
areas: upper jaw, lower jaw, incisors and canines. The
normality distribution of the data was checked with the
Shapiro-Wilk test.
Data were analyzed using non-parametric statistics,
which are more powerful when the data show a skewed
distribution. Thus, the Wilcoxon signed rank-sum test
was more appropriate to ascertain the significant differ-
ences between the individual rinse solutions to compare
the difference between the test and control. Data con-
s i d e r i n gt h eV A S - s c o r e so ft h eq u e s t i o n n a i r ew e r ea l s o
analyzed using the same test.
All data were registered electronically using Microsoft
Excel and statistical analyses were carried out using the
statistical package Intercooled Stata I2. All tests were
used in the two-tailed version and p-values ≤ 0.05 were
considered as statistically significant.
Results
All subjects (N = 30) completed the trial, and there were
no missing values. The amounts of mouthwashes used
indicated good compliance with the instructions. No
adverse events or side effects were reported or observed.
The plaque scores for the test and control groups at the
end of the experimental period are shown in Table 1.
Statistical analysis showed that there was a significant
difference in the plaque index between the two groups.
In the control group, the mean overall plaque index was
2.46 compared to 2.18 of the test group after the 3-day
non-brushing experimental period. The difference of
0.28 between the two groups was statistically significant
(p < 0.05). The EO mouthwash with ethanol shows bet-
ter inhibitory effect of plaque regrowth in 3 days than
the mouthwash test of the whole mouth (plaque index =
2.18 against 2.46, respectively, p < 0.05); for the lower
jaw (plaque index = 2.28 against 2.57, respectively, p <
0.05); for the upper jaw (plaque index = 2.08 against
2.35, respectively, p < 0.05); for incisors (plaque index =
1.93 against 2.27, respectively, p < 0.05) than for the
canines (plaque index = 1.99 against 2.47, respectively, p
< 0.05).
The subjects completed the questionnaire after each
experimental period and the results are shown in
Table 2.
With regard to the subjects’ rating of the rinsing time
(question 5), the results demonstrated a difference
between the test and control groups (6.50 and 4.23
respectively, p < 0.005). This suggest than the rinsing
time of EO with alcohol seemed longer than EO without
alcohol, probably due to the typical burning effect of EO
with alcohol.
They also considered EO with alcohol (VAS 6.07) as
more effective in reducing plaque in the mouth com-
pared to the EO without alcohol (VAS 4.97; p < 0.05).
However, with respect to the other questions (taste
perception, duration of taste, alteration in taste percep-
tion and convenience), the statistically significant differ-
ences were not noted between the groups.
Discussion
Essential oil mouthwashes are used for many years in
the prevention and treatment of periodontal disease.
The effectiveness of the EO mouthwash in controlling
plaque was demonstrated in many clinical trials, both
long- and short-term. In short-term studies [30-33], EO
significantly reduced plaque accumulation in the 4- and
21-days plaque regrowth models. However, when the
EO rinse was compared to the CHX formulation, the
latter showed better antiplaque effects. In contrast,
recent studies [34,35] have demonstrated that the EO
rinse was as effective as the CHX rinse in inhibiting pla-
q u er e g r o w t h .T h ee f f e c t i v e n e s so ft h eE Or i n s ew a s
also demonstrated in long-term studies [5,8,9,11,36] in
which it was used as a supplement to mechanical
hygiene measures. In those studies, which varied in
length from 3 to 9 months, the EO-containing
mouthwash significantly reduced plaque accumulation
and gingivitis when compared to the placebo. Although,
EO formulations were less effective in reducing supra-
gingival plaque accumulation than CHX [9], in contrast
a more recent study [12] has demonstrated that the EO
mouthwash and the CHX mouthwash have comparable
antiplaque and antigingivitis activity. Furthermore,
Table 1 Total Plaque Index (Mean ± SD) for the Test and
Control Groups (N = 30)
EO with alcohol EO without alcohol p value*
Overall 2.18 ± 0.39 2.46 ± 0.42 < 0.001
All vestibular 2.51 ± 0.49 2.88 ± 0.58 < 0.001
All lingual 1.86 ± 0.45 1.86 ± 0.57 ns
Incisors 1.93 ± 0.48 2.27 ± 0.59 < 0.001
Canines 1.99 ± 0.46 2.47 ± 0.56 < 0.001
Premolars 2.13 ± 0.41 2.40 ± 0.48 0.003
Molars 2.64 ± 0.49 2.75 ± 0.37 ns
*Using Wilcoxon signed-rank test.
ns: no statistically significant difference between EO with alcohol and EO
without alcohol was found.
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rinses were equally effective in reducing gingival index
scores and the number of bleeding sites [9,12,37].
Finally, in a recent systematic review [38], the authors
concluded that although the effects of CHX ensure
higher control of plaque, there are no marked differ-
ences in the control of gingival inflammation. Therefore,
the EO mouthwash appears to be a reliable alternative
to the CHX mouthwash in those cases where the dental
professional has judged that long-term anti-inflamma-
tory oral care may be beneficial, while for indications
where plaque control is the focus, a CHX mouthwash
remains the first choice. All the studies reviewed refer
to the EO mouthwash with its traditional formulation,
containing alcohol. Alcohol is present in many
mouthwashes and is used as a solvent of the ingredients
and the preservative of the preparation. The antiseptic
effect, however, seems to be negligible at the concentra-
tions used in mouthwashes [22]. In vitro studies have
shown that the alcohol promotes the mucosal penetra-
tion of the various carcinogens found in tobacco [39], in
addition causing direct damage on the oral mucosa [40].
The bulk of the metabolism of alcohol is carried out in
the liver but there is evidence that demonstrates the
ability of some oral bacteria to metabolize alcohol to
acetaldehyde, a carcinogenic substance [41]. For many
years, researchers have been discussing the safety of
alcohol in mouthwashes for daily use and several case-
control studies suggest the correlation of alcohol use in
mouthwashes with oral cancer [27].
Epidemiological studies, however, are often inconsis-
tent and many reviews conclude there are no data
demonstrating the direct correlation between alcohol
containing mouthwashes and oral cancer [42,43].
Recently, Werner and Seymour [44] have reviewed the
two most recent revisions on the role of alcohol in the
onset of oral cancer [27,45], stating that there is evi-
dence showing the existence of this association, but
these are still weak and inconclusive, and randomized
clinical trials would be needed on a large sample to ver-
ify this hypothesis. These authors concluded that the
benefit of alcohol in mouthwashes is negligible and it
may carry a risk of oral cancer, which is difficult to
quantify, and so it is preferable not to prescribe or
recommend them.
The purpose of this study was to evaluate whether a
new alcohol-free mouthwash with EO had the same
characteristics as the antiplaque traditional alcohol-con-
taining formulation, used as a control. It used a 3-day
non-brushing model that allowed for plaque accumula-
tion that was already used by several authors to evaluate
the effects of various mouthwashes [29,46-49]. In addi-
tion, it was investigated through a questionnaire that
assessed the volunteers’ perception in terms of effective-
ness, utility, and taste of the products examined.
The results reject the null hypothesis that there are no
differences between the mouthwash test without alcohol
and the control with alcohol, in favor of the traditional
product with alcohol. The difference in efficacy, as
assessed by the plaque index, is modest but statistically
significant. There were no differences between the two
groups in terms of compliance, taste perception, dura-
tion of taste, alteration in taste perception and conveni-
ence, while the volunteers considered the mouthwash
with alcohol more effective in reducing plaque
formation.
Conclusions
This 3-day plaque regrowth study showed that the EO
containing mouthwash without alcohol was a less potent
plaque inhibitor than the traditional alcohol containing
EO mouthwash. It appears that the subjects appreciated
the effect on plaque reduction of the traditional
mouthwash better.
Footnotes
* Department of Health Sciences, School of Dentistry,
University of L’Aquila, Italy.
Table 2 Questionnaire Responses (Mean ± SD) Determined by VAS
Question Response EO with
alcohol
EO without
alcohol
p
value*
1) How was the taste of the product? Very bad Very good 5.17 ± 2.73 6.6 ± 2.27 ns
2) How long did the taste remain in the mouth after
rinsing?
Very long Very short 5.97 ± 1.71 5.5 ± 2.36 ns
3) How was your taste of food and drinks affected? Negative
change
Positive change 2.3 ± 3.02 2.97 ± 3.27 ns
4) Was the use of the mouth rinse convenient? Not convenient Very
convenient
5.83 ± 1.68 5.13 ± 2.58 ns
5) What is your opinion about the rinsing time? Very long Very short 4.23 ± 2.88 6.5 ± 2.46 0.0025
6) What was your perception of the plaque reduction? Insufficient Very efficient 6.07 ± 2.52 4.97 ± 2.72 0.016
*Using Wilcoxon signed-rank test.
ns: no statistically significant difference between EO with alcohol and EO without alcohol was found.
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